Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma |
|---|---|
| Full Title | Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma |
| Disease/Condition | Pediatric Hematology/Oncology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Lisa Figueiredo |
| Contact Name | Joyce Brown |
| Contact Email | joycbrow@montefiore.org |
| Protocol Number | IRB# 2016-5998 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
| Adult, Pediatric, Both | Adult |
